Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.5 CHF | +0.42% | +1.39% | -3.16% |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Apr. 25 | Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 * | 8.29M 9.08M | Sales 2024 * | 51.09M 55.94M | Capitalization | 87.54M 95.85M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 10.6 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.71 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 46 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.73% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 day | +0.42% | ||
1 week | +1.39% | ||
Current month | -2.76% | ||
1 month | -2.06% | ||
3 months | -1.55% | ||
6 months | -25.20% | ||
Current year | -3.16% |
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 9.5 | +0.42% | 80,057 |
24-04-24 | 9.46 | -1.97% | 24,493 |
24-04-23 | 9.65 | +1.26% | 18,707 |
24-04-22 | 9.53 | +4.61% | 4,889 |
24-04-19 | 9.11 | -2.77% | 30,815 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.16% | 95.38M | |
+4.16% | 70.78B | |
+10.74% | 9.15B | |
-17.03% | 4.84B | |
+37.51% | 4.22B | |
+3.92% | 3.92B | |
+18.14% | 2.55B | |
-24.13% | 2.26B | |
-29.70% | 2.24B | |
+9.09% | 1.92B |
- Stock Market
- Equities
- SANN Stock